premargin

Element List	Explanation
Introduction	Al Majed For Oud Company announces the execution of a memorandum of understanding with Mr. Othman Abdullah Othman Al-Suwaih; and Mr. Abdullah Othman Abdullah Al-Suwaih, and Mr. Amr Othman Abdullah Al-Suwaih and to potentially acquire 100% of Al Safa Pharmaceuticals and Medical Supplies Limited Liability Company’s share capital with commercial registration number 1010148073 (the “Proposed Transaction”).
Memorandum Signing Date	2025-12-30 Corresponding to 1447-07-10
Counterparty	Mr. Othman Abdullah Othman Al-Suwaih Mr. Abdullah Othman Abdullah Al-Suwaih Mr. Amr Othman Abdullah Al-Suwaih
Memorandum Subject	To provide Al Majed For Oud Company with the sole and exclusive right to acquire the entire share capital of Al Safa Pharmaceuticals and Medical Supplies Limited Liability Company from Mr. Othman Abdullah Othman Al-Suwaih Mr.Abdullah Othman Abdullah Al-Suwaih and Mr. Amr Othman Abdullah Al-Suwaih.
Memorandum Duration	The Memorandum of Understanding shall be valid for a period of Six (6) months. And it may be extended upon mutual and written agreement of the Parties.
Related Parties	There are no related parties
Financial Impact	The financial impact cannot be determined at this stage, as the Memorandum of Understanding relates to the evaluation of the Proposed Transaction and the conduct of due diligence. Accordingly, the impact of the Proposed Transaction on Al Majed For Oud Company’s financial statements has not yet been determined.
Additional Information	Al Majed For Oud Company will make any material disclosures related to the Proposed Transaction in due course.